Hydrochloric acid, secreted by parietal cells in the stomach lining, is what converts pepsinogen into pepsin. When pepsinogen encounters the strongly acidic environment of the gastric lumen, the low pH triggers a structural change that strips away a blocking segment of the protein, revealing the active enzyme underneath. The process is fast, self-reinforcing, and more layered than a simple acid bath might suggest.
How Acid Triggers the Conversion
Pepsinogen is what biochemists call a zymogen, an inactive precursor of an enzyme. It is produced and stored in this dormant form for a good reason: if it were active inside the cells that made it, it would start digesting them. The molecule carries an extra stretch of amino acids at one end, called a prosegment, that physically blocks the enzyme’s active site and keeps it locked in an inactive shape.1Biochemical Journal. Mechanism of activation of the gastric aspartic proteinases: pepsinogen, progastricsin and prochymosin Think of it as a cap wedged into the keyhole of a lock: the enzyme machinery is all there, but nothing can get in.
Once pepsinogen is released into the stomach, the hydrochloric acid drives the pH down to roughly 1.5 to 3. At that acidity, the prosegment loses the electrostatic interactions holding it in place, unfolds away from the active site, and is clipped off. The resulting protein is pepsin, fully capable of breaking down dietary proteins. Chief cells secrete pepsinogen in its inactive form, and the acidic stomach environment performs the activation step.2PubMed Central. A tool for predicting pH and temperature effects on porcine and human pepsin activity during in vitro gastric digestion
Two Routes to Activation
The conversion does not happen by just one route. There are actually two overlapping pathways, and understanding both helps explain why the process is so efficient.
The first is intramolecular activation: a single pepsinogen molecule, on encountering acid, essentially activates itself. The low pH destabilizes the prosegment, and the molecule’s own chemistry cleaves it off. This happens quickly, within a couple of minutes of acid exposure, and produces a pepsin molecule with a consistent, uniform structure.3Journal of Biological Chemistry. Conversion of pepsinogen to pepsin. Further evidence for intramolecular and pepsin catalyzed activation
The second is intermolecular or autocatalytic activation: once some pepsin molecules already exist in the mixture, they act on remaining pepsinogen molecules and chop off their prosegments. This is the snowball effect. A small amount of pepsin creates more pepsin, which creates still more, accelerating the whole process. The pepsin produced by this second route is slightly less uniform, with the prosegment cut at slightly varied positions.3Journal of Biological Chemistry. Conversion of pepsinogen to pepsin. Further evidence for intramolecular and pepsin catalyzed activation Researchers have modeled this dual system mathematically, treating the autocatalytic step much like a classic enzyme-substrate reaction, complete with a measurable binding affinity between active pepsin and its pepsinogen target.4PubMed. Kinetics of intra- and intermolecular zymogen activation with formation of an enzyme-zymogen complex
In practical terms, the intramolecular route gets things started, and the autocatalytic route amplifies the signal. Together, they ensure that the stomach goes from storing an inert precursor to wielding a powerful protein-digesting enzyme in a matter of minutes after a meal triggers acid secretion.
What Makes Chief Cells Release Pepsinogen in the First Place
The activation story begins a step earlier, with the signals that tell chief cells to dump their stores of pepsinogen into the stomach. Chief cells sit deep in the gastric glands of the stomach lining, and they respond to both neural and hormonal cues.
The nerve signal comes through the vagus nerve, which releases the neurotransmitter acetylcholine when you eat, or even when you see and smell food. In chief cells, acetylcholine binds to two types of muscarinic receptors, called M1 and M3. Studies in knockout mice showed that removing either receptor alone only partially reduced pepsinogen release, but eliminating both nearly abolished it, confirming that both receptor types work together to drive secretion.5PubMed. Cholinergic agonist-induced pepsinogen secretion from murine gastric chief cells is mediated by M1 and M3 muscarinic receptors
Hormonal signals add another layer. Cholecystokinin, a gut hormone released when fats and proteins reach the small intestine, also stimulates pepsinogen secretion. Gastrin, the hormone best known for telling parietal cells to produce acid, can bind to the same receptor on chief cells that cholecystokinin uses, though it is a weaker trigger and only partially stimulates release compared to cholecystokinin.6PubMed. Partial agonism by gastrin for a cholecystokinin receptor mediating pepsinogen secretion The net effect is that when you eat a protein-rich meal, the nervous system and gut hormones coordinate to flood the stomach lumen with pepsinogen at roughly the same time acid production ramps up, setting the stage for rapid activation.
Why the Stomach Does Not Digest Itself
If pepsin can break down proteins, and the stomach wall is made of protein, the obvious question is why the stomach survives. The answer lies in a mucus-bicarbonate barrier that coats the inner surface of the stomach. This adherent gel layer serves two protective roles at once: it traps bicarbonate ions secreted by surface epithelial cells, creating a pH gradient from the near-neutral surface of the stomach wall to the highly acidic lumen, and it physically blocks pepsin from reaching the underlying tissue.7PubMed. Gastroduodenal mucus bicarbonate barrier: protection against acid and pepsin
Under normal conditions this barrier is remarkably effective. The mucus layer is constantly being secreted, eroded, and replenished, maintaining a stable shield. Problems arise when the barrier is compromised, whether by chronic use of non-steroidal anti-inflammatory drugs, infection with Helicobacter pylori, heavy alcohol intake, or other insults. When the mucus thins or the bicarbonate output drops, acid and pepsin gain access to the epithelial surface, and the result can be gastritis or peptic ulceration. It is worth noting that the duodenum, which receives acidic chyme from the stomach, has an even more robust mucus bicarbonate barrier for protection.7PubMed. Gastroduodenal mucus bicarbonate barrier: protection against acid and pepsin
Pepsin Outside the Stomach
One of the more surprising findings in recent decades is that pepsin does not always stay where it belongs. In people with gastroesophageal reflux or laryngopharyngeal reflux, pepsin can travel upward into the esophagus, throat, and even the airways. And the enzyme turns out to be hardier than you might expect outside the stomach’s acid bath.
Pepsin remains structurally stable at pH levels up to about 7, meaning it survives in the near-neutral environment of the throat and larynx even though it is not actively digesting anything at that pH. If the tissue is then re-exposed to even a mild acid pulse, the enzyme regains its proteolytic activity and starts damaging tissue.8PubMed Central. Reflux revisited: advancing the role of pepsin Even without reacidification, pepsin can cause harm. Research has shown that laryngeal epithelial cells actively take up pepsin through a receptor-mediated process, pulling the enzyme inside the cell where it can be reactivated in acidic intracellular compartments. Once inside, pepsin damages mitochondria and triggers inflammatory gene expression patterns that resemble those seen in severe reflux disease.9PLOS ONE. Weak acid and pepsin reflux induce laryngopharyngeal mucosal barrier injury: A rabbit-model-based study
This helps explain why some patients with reflux-related throat symptoms do not respond well to acid-suppressing medications alone. Standard proton pump inhibitors reduce acid production, but they do not eliminate pepsin. If pepsin is already deposited on laryngeal tissue, suppressing acid may not be enough to prevent the cellular uptake and intracellular damage that the enzyme causes on its own. The recognition of pepsin as an independent injury agent has shifted how researchers think about treating extraesophageal reflux, with growing interest in approaches that target or neutralize the enzyme directly rather than focusing only on acid.
Pepsin Is Not Universal Across the Lifespan
The pepsinogen-to-pepsin story gets more interesting when you look at how it changes during development. The stomach does not produce the same mix of digestive enzymes from birth through adulthood. In young mammals, chief cells express a different set of zymogens than in adults.
Studies in rats have shown that neonatal and infant stomachs predominantly express pepsinogen F and prochymosin, two zymogens better suited to digesting milk proteins, particularly casein. As the animal matures and transitions to solid food, gene expression switches over to pepsinogen C, the adult-type form that gives rise to the pepsin we have been discussing.10Biochemical and Biophysical Research Communications. Molecular Cloning of Neonate/Infant-Specific Pepsinogens from Rat Stomach Mucosa and Their Expressional Change during Development This gene-expression switch is not random; it appears to be regulated by steroid hormones, particularly corticosteroids that rise around weaning age.11PubMed Central. Pepsinogens, progastricsins, and prochymosins: structure, function, evolution, and development
Chymosin, the enzyme produced from prochymosin, is the same enzyme historically used to curdle milk in cheese production. Its presence in infant stomachs makes biological sense: a newborn mammal’s diet is entirely liquid milk, and chymosin is particularly efficient at clotting and digesting milk casein, slowing its transit through the stomach so the intestine has more time to absorb nutrients. As the diet diversifies, the stomach retires the milk-specialist enzyme and ramps up production of pepsin, the generalist protein-digester.
How Activation Differs Across Species
The basic mechanism of acid-triggered prosegment removal is ancient and conserved across vertebrates, but evolution has tuned the details to suit different physiological conditions. A comparative study of pepsinogen C genes across vertebrates revealed that fish pepsinogens have a shorter prosegment with fewer basic amino acid residues than their counterparts in land-dwelling animals. This structural difference shifts the pH at which activation occurs: fish pepsinogens appear to activate under conditions that are comparatively more alkaline than what is needed for mammalian pepsinogens.12PLoS ONE. The Evolution of Pepsinogen C Genes in Vertebrates: Duplication, Loss and Functional Diversification
This makes sense when you consider that fish stomachs tend to operate at somewhat higher pH values than mammalian stomachs, and their body temperatures are lower, which affects enzyme kinetics. The prosegment essentially acts as a pH-sensitive switch, and evolution has adjusted that switch’s set point to match each species’ gastric chemistry. In tetrapods like mammals, amphibians, and reptiles, the isoelectric point values of the prosegment and enzyme regions indicate activation requires a more strongly acidic environment, generally below pH 3.5. In teleost fish, the corresponding values sit closer to 4, reflecting their less acidic stomachs.12PLoS ONE. The Evolution of Pepsinogen C Genes in Vertebrates: Duplication, Loss and Functional Diversification
Some vertebrates have lost their pepsinogen genes entirely. Certain fish lineages that evolved to lack stomachs, such as carp and zebrafish, have also lost the pepsinogen genes that would be useless without an acidic chamber to activate them. This underscores how tightly the pepsinogen system is linked to stomach acid: without one, the other has no function and is discarded by evolution.
Why the Body Stores an Inactive Precursor at All
Storing digestive enzymes as inactive zymogens is not unique to pepsinogen. The pancreas does the same thing with trypsinogen, chymotrypsinogen, and several other enzymes that are activated only after they reach the small intestine. The strategy serves a clear purpose: it separates the site of production from the site of action. Chief cells can manufacture and stockpile large quantities of pepsinogen in membrane-bound granules, ready to flood the stomach lumen on demand, without any risk of self-digestion during storage.
When that safety mechanism fails in other organs, the consequences are severe. In acute pancreatitis, for example, trypsinogen activates prematurely inside the pancreas rather than in the intestine, and the resulting enzymatic self-digestion causes intense inflammation and tissue destruction. The stomach’s version of this fail-safe is arguably more elegant: the activating agent, hydrochloric acid, is produced by an entirely different cell type (parietal cells) in a separate part of the gastric gland, and the pepsinogen only encounters that acid after both secretions have been released into the open lumen. This physical separation is a built-in safeguard.
Measuring Pepsinogen as a Health Marker
Because pepsinogen is produced in such a regulated way, measuring its levels in the blood can provide indirect information about the health of the stomach lining. A small fraction of the pepsinogen produced by chief cells leaks into the bloodstream rather than entering the stomach, and blood tests can quantify it. Clinicians sometimes use the ratio between two pepsinogen isoforms, pepsinogen I and pepsinogen II, as a noninvasive screen for chronic atrophic gastritis, a condition in which the stomach lining thins and loses its acid-secreting and enzyme-secreting glands over time.
In atrophic gastritis, the cells that produce pepsinogen I are preferentially lost, so the pepsinogen I level drops and the ratio between the two forms falls. A low ratio can flag patients who might benefit from endoscopy to check for precancerous changes. This “serological biopsy” approach has been adopted widely in East Asian countries where stomach cancer rates are high, though its sensitivity and specificity vary depending on the population studied and the cutoff values chosen. It is not a definitive diagnostic on its own, but it is a useful triage tool that takes advantage of the fact that pepsinogen output reflects the structural integrity of the gastric mucosa.
Pepsin detection has also become relevant outside of traditional gastroenterology. Because pepsin travels with refluxate into the throat and airways, saliva and sputum tests for pepsin are being explored as diagnostic tools for laryngopharyngeal reflux. Finding pepsin in a saliva sample is strong evidence that gastric contents are reaching the upper airway, which can help distinguish reflux-related throat complaints from other causes of chronic cough, hoarseness, or throat clearing.8PubMed Central. Reflux revisited: advancing the role of pepsin Rapid lateral-flow tests for salivary pepsin already exist commercially, though their clinical utility is still being refined.